RESULTS OF THERAPEUTIC DRUG MONITORING COMBINATION THERAPY OF ANTICONVULSANTS IN CLINICAL PRACTICS

RESULTS OF THERAPEUTIC DRUG MONITORING COMBINATION THERAPY OF ANTICONVULSANTS IN CLINICAL PRACTICS

Abstract: this paper presents the results of therapeutic drug monitoring (TDM) of anticonvulsants – valproats and carbamazepins. Analysis include 800 patients with epilepsy in clinical practices, who received monotherapy and drug combinations. We determine plasma concentrations in two points: Cmin –...

Full description

Bibliographic Details
Main Authors:	M. V. Leonova, Yu. B. Belousov, I. F. Tischenkova, L. L. Shteinberg, A. V. Sokolov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2016-05-01
Series:	Эпилепсия и пароксизмальные состояния
Subjects:	therapeutic drug monitoring anticonvulsants valproats carbamazepine drug interactions epilepsy
Online Access:	https://www.epilepsia.su/jour/article/view/70

Similar Items

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CLINICAL PRACTICS
by: Yu. B. Belousov, et al.
Published: (2016-05-01)

THERAPEUTIC DRUG MONITORING OF ANTICONVULSANTS IN CHILDREN IN CLINICAL PRACTICE
by: M. V. Leonova, et al.
Published: (2017-05-01)

Vitamin D status among children and adolescents on anticonvulsant drugs in Southern Switzerland
by: Vera Ramelli, et al.
Published: (2014-08-01)

Therapeutic Drug Monitoring of Carbamazepine: A 20-Year Observational Study
by: Grzegorz Grześk, et al.
Published: (2021-11-01)

THERAPY FOR EPILEPSY IN MIDDLE-AGED AND ELDERLY PATIENTS
by: P. N. Vlasov, et al.
Published: (2009-03-01)

Therapeutic drug monitoring in epilepsy: an alternative approach
by: A. A. Rodyonov, et al.
Published: (2017-02-01)

Therapeutic drug monitoring and methods of quantitation for carbamazepine
by: Cristian Tuchila, et al.
Published: (2017-10-01)

Eslicarbazepine, but Not Lamotrigine or Ranolazine, Shows Anticonvulsant Efficacy in Carbamazepine-Resistant Rats Developed by Window-Pentylenetetrazole Kindling
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-05-01)

Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
by: Matthew D. Krasowski
Published: (2010-06-01)

Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd
by: Abolghasem Rahimdel, et al.
Published: (2016-11-01)

Where next for antiepileptic therapeutic drug monitoring?
by: Janković Slobodan M.
Published: (2019-01-01)

Generalized epilepsies: current conceptions and therapeutic approaches
by: L R Zenkov
Published: (2012-03-01)

THERAPEUTIC DRUG MONITORING OF LAMOTRIGINE: DEVELOPMENT OF PHARMACOKINETIC APPROACHES AIMING AT THE INDIVIDUAL-BASED ANTICONVULSIVE PHARMACOTHERAPY
by: D. A. Abaimov, et al.
Published: (2016-05-01)

Evaluation of Osteoporosis Among Epileptic Patients on Monotherapy
by: Mufeed Akram Taha, et al.
Published: (2024-03-01)

Anticonvulsants and Bone Mineral Density
by: J Gordon Millichap
Published: (1995-09-01)

EPIDEMIOLOGIC RESEARCH ON EPILEPSY IN MINSK
by: T. V. Dokukina, et al.
Published: (2015-03-01)

Antiepileptic drugs prescribed in pregnancy and prevalence of major congenital malformations: comparative prevalence studies
by: Petersen I, et al.
Published: (2017-02-01)

Comparing the effect of sodium valproate and carbamazepine on sexual function satisfaction in men with epilepsy in Hamadan city
by: Mehrdokht Mazdeh, et al.
Published: (2018-01-01)

Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study
by: Gellan K. Ahmed, et al.
Published: (2021-11-01)

Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study
by: Kannan Sridharan, MD, DM, et al.
Published: (2020-01-01)

Residues of Selected Anticonvulsive Drugs in Surface Waters of the Elbe River Basin (Czech Republic)
by: Martin Ferencik, et al.
Published: (2022-12-01)

Therapeutic drug monitoring in epilepsy clinic: a multi-disciplinary approach
by: Sunee Lertsinudom, et al.
Published: (2014-12-01)

Anticonvulsant Drugs and Severe Adverse Cutaneous Drug Reactions: A Longitudinal Observational Study
by: Abbas Darjani, et al.
Published: (2019-08-01)

Choosing Old and New Antiepileptic Drugs in Epilepsy Treatment
by: Semai Bek, et al.
Published: (2009-06-01)

Trends in Choosing Conventional Versus New Antiepileptic Drugs in Epilepsy Treatment
by: Gençer GENÇ, et al.
Published: (2016-08-01)

Aggravation of symptomatic occipital epilepsy of childhood by carbamazepine
by: Škrijelj Fadil E., et al.
Published: (2014-01-01)

Bone Mineral Density in Patients Receiving Anticonvulsant Drugs
by: Kadir Yıldırım, et al.
Published: (2002-12-01)

LC–MS<sup>3</sup> Strategy for Quantification of Carbamazepine in Human Plasma and Its Application in Therapeutic Drug Monitoring
by: Dongxiao Ma, et al.
Published: (2022-02-01)

Carbamazepine and carbamazepine-epoxide concentrations in mothers, colostrum, and breastfed newborns: Comparison with concentrations determined during delivery and in the mature milk period
by: Ivana Kacirova, et al.
Published: (2022-07-01)

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS
by: A. V. Yakunina, et al.
Published: (2016-12-01)

Drug interchangeability: Clinical efficacy and safety
by: S. K. Zyryanov, et al.
Published: (2017-06-01)

Comparison of the probability of four anticonvulsant mood stabilizers to facilitate polycystic ovary syndrome in women with epilepsies or bipolar disorder—A systematic review and meta-analysis
by: Jing Guo, et al.
Published: (2023-05-01)

An observational case-control study comparing the recovery profile in patients receiving additional dose of anticonvulsant vs. regular dose during supratentorial craniotomy
by: Rosen Roy Mathew, et al.
Published: (2020-01-01)

PROBABLE ANTICONVULSIVE MECHANISMS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION AND PREDICTORS OF ITS EFFECTIVITY
by: O. V. Kisten, et al.
Published: (2016-05-01)

Evaluation of the clinical and quantitative performance of a practical HPLC-UV platform for in-hospital routine therapeutic drug monitoring of multiple drugs
by: Go Morikawa, et al.
Published: (2023-10-01)

Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters
by: Teresa Iannaccone, et al.
Published: (2021-03-01)

Decrease in the effectiveness of valproic acid against the background of antibacterial therapy with imipenem/cilastatin in pediatric practice: A case report
by: A. B. Strok, et al.
Published: (2024-01-01)

The effects of gabapentin in the treatment of neuropathic pain: a small sample randomized controlled clinical trial
by: Sheng⁃nian ZHOU, et al.
Published: (2010-12-01)

Pharmacokinetic Simulation Study: Exploring the Impact of Clinical Parameters on Lamotrigine for Different Patient Populations with Implications for Liver Function Assessment and Therapeutic Drug Monitoring
by: Bárbara Costa, et al.
Published: (2024-02-01)

Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
by: Changhee Ha, et al.
Published: (2021-08-01)